Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Teligent, Inc.TLGT · Entity 134764 | Director | January 04, 2021 | January 06, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Teligent, Inc.
Report date January 04, 2021 · Filed January 06, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $0.74 · Expires 2031-01-04 | Direct | 2,000 |
Reported balance
After 2021-01-04 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-01-04 · Grant · Acquired 2,000 · Balance 2,000 F2: These securities were granted as part of the Issuer's equity compensation to its non-employee directors. F1: These shares shall vest fully 12 months from the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares shall vest fully 12 months from the date of grant.
F2: These securities were granted as part of the Issuer's equity compensation to its non-employee directors.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Merck & Co., Inc.
Report date November 03, 2009 · Filed November 04, 2009
Section 16 reporting ended · disclosed 2009-11-04. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 1
1 source rowRow 1 · 2009-11-03 · Disposition to issuer · Disposed 10,619 · Balance 0 F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. |
| Deferred Stock Unit AwardSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2009-11-03 · Disposition to issuer · Disposed 20,000 · Balance 0 F2: Each deferred stock unit ("DSU") is the economic equivalent of one share of common stock. F4: In connection with the Merger, the DSU's will be paid to the reporting person in accordance with the terms of the Issuer's 2006 Stock Incentive Plan. F3: Pursuant to the Merger Agreement, upon closing of the Merger, the DSU's were converted into DSU's over common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.33 · Expires 2013-03-19 | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2009-11-03 · Disposition to issuer · Disposed 75,000 · Balance 0 F6: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $19.23 · Expires 2013-05-18 | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2009-11-03 · Disposition to issuer · Disposed 50,000 · Balance 0 F6: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.57 · Expires 2014-04-30 | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2009-11-03 · Disposition to issuer · Disposed 80,000 · Balance 0 F6: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $18.85 · Expires 2015-04-30 | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2009-11-03 · Disposition to issuer · Disposed 58,000 · Balance 0 F6: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter. |
| Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $22.91 · Expires 2016-04-30 | Direct | 0 |
Reported balance
After 2009-11-03 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2009-11-03 · Disposition to issuer · Disposed 57,300 · Balance 0 F6: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash.
F2: Each deferred stock unit ("DSU") is the economic equivalent of one share of common stock.
F3: Pursuant to the Merger Agreement, upon closing of the Merger, the DSU's were converted into DSU's over common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement.
F4: In connection with the Merger, the DSU's will be paid to the reporting person in accordance with the terms of the Issuer's 2006 Stock Incentive Plan.
F5: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter.
F6: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 04, 2021 Filed Jan 6, 2021 10:44 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 2,000 | $0.00 Strike: $0.74 | $0.00 |
DisclosureSEC source: 0000352998-21-000001 · primary_doc.xml · derivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 Underlying: Common Stock · 2,000 shares Expires 2031-01-04 F2 · price: These securities were granted as part of the Issuer's equity compensation to its non-employee directors. F1 · derivative.exercise_date: These shares shall vest fully 12 months from the date of grant. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 10:58 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $0.42 | $0.00 |
DisclosureSEC source: 0001104659-20-000639 · tm201128d5_4.xml · derivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2030-01-02 F2 · price: These securities were granted as part of the Issuer's equity compensation to its non-employee directors. F1 · derivative.exercise_date: These securities shall vest fully 12 months from the date of grant. Read SEC document |
| October 02, 2019 Filed Oct 4, 2019 18:00 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 12,784 | $0.00 Strike: $0.88 | $0.00 |
DisclosureSEC source: 0001144204-19-047420 · tv530700_form4.xml · derivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,784 Underlying: Common Stock · 12,784 shares Expires 2029-10-02 F1 · security: These securities were issued pursuant to the terms of the Non-employee Directors Compensation Policy as compensation for services provided to the Board for the fourth quarter of 2019. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 11:42 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 17,308 | $0.00 Strike: $0.65 | $0.00 |
DisclosureSEC source: 0001144204-19-033721 · tv524757_form4.xml · derivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,308 Underlying: Common Stock · 17,308 shares Expires 2029-07-01 F1 · security: These securities were issued pursuant to the terms of the Non-employee Directors Compensation Policy as compensation for services provided to the Board for the third quarter of 2019. Read SEC document |
| May 13, 2019 Filed May 15, 2019 18:23 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 13,081 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001144204-19-026690 · tv521750_form4.xml · derivative · entry 2 KOEHLER STEVEN H · CIK 0001144776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,081 Underlying: Common Stock · 13,081 shares Expires 2029-05-13 F2 · security: These securities were issued pursuant to the terms of the Non-employee Director Compensation Policy as compensation for services provided to the Board in the second quarter of 2019. Read SEC document |
| May 13, 2019 Filed May 15, 2019 18:23 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 13,081 | $0.00 Strike: $0.86 | $0.00 |
DisclosureSEC source: 0001144204-19-026690 · tv521750_form4.xml · derivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,081 Underlying: Common Stock · 13,081 shares Expires 2029-05-13 F1 · security: These securities were issued pursuant to the terms of the Non-employee Director Compensation Policy as compensation for services provided to the Board in the first quarter of 2019. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 16:02 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $1.32 | $0.00 |
DisclosureSEC source: 0001144204-19-000656 · tv510285_4.xml · derivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2029-01-02 F2 · price: These securities were granted as part of the Issuer's equity compensation to its non-employee directors. F1 · derivative.exercise_date: These securities shall vest fully 12 months from the date of grant. Read SEC document |
| January 02, 2018 Filed Jan 4, 2018 16:14 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $3.85 | $0.00 |
DisclosureSEC source: 0001144204-18-000817 · tv482603_form4.xml · derivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2028-01-02 F2 · price: These securities were granted as part of the Issuer's equity compensation to its non-employee directors. F1 · derivative.exercise_date: These securities shall vest fully 12 months from the date of grant. Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 17:01 UTC | Teligent, Inc. TLGT · Entity 134764 | PurchaseCommon Stock | 300 | $3.61 | $1,084.02 |
DisclosureSEC source: 0001144204-17-058440 · tv479212_form4.xml · nonDerivative · entry 3 KOEHLER STEVEN H · CIK 0001144776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 17:01 UTC | Teligent, Inc. TLGT · Entity 134764 | PurchaseCommon Stock | 2,900 | $3.62 | $10,490.46 |
DisclosureSEC source: 0001144204-17-058440 · tv479212_form4.xml · nonDerivative · entry 2 KOEHLER STEVEN H · CIK 0001144776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,700 Read SEC document |
| November 10, 2017 Filed Nov 13, 2017 17:01 UTC | Teligent, Inc. TLGT · Entity 134764 | PurchaseCommon Stock | 1,800 | $3.62 | $6,513.84 |
DisclosureSEC source: 0001144204-17-058440 · tv479212_form4.xml · nonDerivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,800 Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 16:06 UTC | Teligent, Inc. TLGT · Entity 134764 | GrantStock Option · Derivative | 20,000 | $0.00 Strike: $7.05 | $0.00 |
DisclosureSEC source: 0001144204-17-000864 · v456316_form4.xml · derivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2027-01-03 F2 · price: These securities were granted as part of the Issuer's equity compensation to its non-employee directors. F1 · derivative.exercise_date: These securities shall vest fully 12 months from the date of grant. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:55 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerOption (right to buy) · Derivative | 57,300 | Not disclosed Strike: $22.91 | Not disclosed |
DisclosureSEC source: 0001209191-09-051071 · c91853_4x1.xml · derivative · entry 7 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 57,300 shares Expires 2016-04-30 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:55 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerOption (right to buy) · Derivative | 58,000 | Not disclosed Strike: $18.85 | Not disclosed |
DisclosureSEC source: 0001209191-09-051071 · c91853_4x1.xml · derivative · entry 6 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 58,000 shares Expires 2015-04-30 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:55 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerOption (right to buy) · Derivative | 80,000 | Not disclosed Strike: $31.57 | Not disclosed |
DisclosureSEC source: 0001209191-09-051071 · c91853_4x1.xml · derivative · entry 5 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 80,000 shares Expires 2014-04-30 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:55 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerOption (right to buy) · Derivative | 50,000 | Not disclosed Strike: $19.23 | Not disclosed |
DisclosureSEC source: 0001209191-09-051071 · c91853_4x1.xml · derivative · entry 4 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 50,000 shares Expires 2013-05-18 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:55 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerOption (right to buy) · Derivative | 75,000 | Not disclosed Strike: $19.33 | Not disclosed |
DisclosureSEC source: 0001209191-09-051071 · c91853_4x1.xml · derivative · entry 3 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 75,000 shares Expires 2013-03-19 F6 · price: Pursuant to the Merger Agreement, upon closing of the Merger, the option was converted into an option to purchase common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F5 · derivative.exercise_date: The options vested and became exercisable (or will vest and become exercisable) on varying dates pursuant to the terms of the plans under which they were granted. Options that had not vested prior to the Merger, vested upon the closing of the Merger or will vest upon the reporting person's termination of employment thereafter. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:55 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerDeferred Stock Unit Award · Derivative | 20,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001209191-09-051071 · c91853_4x1.xml · derivative · entry 2 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Shares · 20,000 shares Expires not disclosed F2 · derivative.exercise_price: Each deferred stock unit ("DSU") is the economic equivalent of one share of common stock. F4 · price: In connection with the Merger, the DSU's will be paid to the reporting person in accordance with the terms of the Issuer's 2006 Stock Incentive Plan. F3 · derivative.exercise_date: Pursuant to the Merger Agreement, upon closing of the Merger, the DSU's were converted into DSU's over common shares of Merck & Co., Inc. in accordance with the exchange ratio set forth in the Merger Agreement. F4 · derivative.expiration_date: In connection with the Merger, the DSU's will be paid to the reporting person in accordance with the terms of the Issuer's 2006 Stock Incentive Plan. Read SEC document |
| November 03, 2009 Filed Nov 4, 2009 22:55 UTC | Merck & Co., Inc. SGP · Entity 2807 | Disposition to issuerCommon Shares | 10,619 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-09-051071 · c91853_4x1.xml · nonDerivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Pursuant to the agreement and plan of merger ("Merger Agreement") between the Issuer and Merck & Co., Inc. ("Merger"), upon closing of the Merger, each common share of the Issuer was converted into 0.5767 shares of Merck & Co., Inc. common stock and $10.50 in cash. Read SEC document |
| May 01, 2009 Filed May 5, 2009 18:04 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 57,300 | Not disclosed Strike: $22.91 | Not disclosed |
DisclosureSEC source: 0000310158-09-000050 · koe728.xml · derivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,300 Underlying: Common Shares · 57,300 shares Expires 2016-04-30 F2 · price: Not Applicable. F1 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2006 Stock Incentive Plan and exercisable in one-third increments on May 1 of 2010, 2011 and 2012. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 19:17 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 6,500 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-09-000034 · koe718.xml · derivative · entry 3 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Shares · 6,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Not Applicable. F5 · price: Not Applicable. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: Not Applicable. Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 19:17 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 2,363 | $23.70 | $56,003.10 |
DisclosureSEC source: 0000310158-09-000034 · koe718.xml · nonDerivative · entry 2 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,619 Read SEC document |
| April 01, 2009 Filed Apr 3, 2009 19:17 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 6,500 | $0.00 | $0.00 |
DisclosureSEC source: 0000310158-09-000034 · koe718.xml · nonDerivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,982 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| March 20, 2009 Filed Mar 24, 2009 14:20 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionDeferred Stock Unit Award · Derivative | 10,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-09-000017 · koe713.xml · derivative · entry 3 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,500 Underlying: Common Shares · 10,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Not Applicable. F5 · price: Not Applicable. F3 · derivative.exercise_date: Not Applicable. F4 · derivative.expiration_date: Not Applicable. Read SEC document |
| March 20, 2009 Filed Mar 24, 2009 14:20 UTC | Merck & Co., Inc. SGP · Entity 2807 | Tax withholdingCommon Shares | 3,518 | $23.66 | $83,235.88 |
DisclosureSEC source: 0000310158-09-000017 · koe713.xml · nonDerivative · entry 2 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,482 Read SEC document |
| March 20, 2009 Filed Mar 24, 2009 14:20 UTC | Merck & Co., Inc. SGP · Entity 2807 | Exercise / conversionCommon Shares | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000310158-09-000017 · koe713.xml · nonDerivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Not Applicable. Read SEC document |
| May 01, 2008 Filed May 5, 2008 20:50 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 58,000 | Not disclosed Strike: $18.85 | Not disclosed |
DisclosureSEC source: 0000310158-08-000034 · koe663.xml · derivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,000 Underlying: Common Shares · 58,000 shares Expires 2015-04-30 F2 · price: Not Applicable. F1 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2006 Stock Incentive Plan and exercisable in one-third increments on May 1 of 2009, 2010 and 2011. Read SEC document |
| March 03, 2008 Filed Mar 5, 2008 14:38 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantDeferred Stock Unit Award · Derivative | 20,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-08-000006 · koe647.xml · derivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,500 Underlying: Common Shares · 20,000 shares Expires not disclosed F1 · derivative.exercise_price: Not Applicable. F4 · price: Not Applicable. F2 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2006 Stock Incentive Plan. All of these shares become deliverable on March 3, 2011. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
| May 01, 2007 Filed May 3, 2007 14:15 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 80,000 | Not disclosed Strike: $31.57 | Not disclosed |
DisclosureSEC source: 0000310158-07-000027 · koe608.xml · derivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Shares · 80,000 shares Expires 2014-04-30 F2 · price: Not Applicable. F1 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2006 Stock Incentive Plan and exercisable in one-third increments on May 1 of 2008, 2009 and 2010. Read SEC document |
| May 19, 2006 Filed May 23, 2006 21:08 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 50,000 | Not disclosed Strike: $19.23 | Not disclosed |
DisclosureSEC source: 0000310158-06-000073 · koe537.xml · derivative · entry 2 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Shares · 50,000 shares Expires 2013-05-18 F6 · price: Not Applicable. F5 · derivative.exercise_date: Granted under Schering-Plough Corporation 2006 Stock Incentive Plan, exerciseable in one-third increments on April 1 of 2007, 2008 and 2009. Read SEC document |
| May 19, 2006 Filed May 23, 2006 21:08 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantDeferred Stock Unit Award · Derivative | 6,500 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-06-000073 · koe537.xml · derivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,500 Underlying: Common Shares · 6,500 shares Expires not disclosed F1 · derivative.exercise_price: Not Applicable. F4 · price: Not Applicable. F2 · derivative.exercise_date: Granted under Schering-Plough Corporation 2006 Stock Incentive Plan. All of the shares become deliverable on April 1, 2009. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
| March 20, 2006 Filed Mar 22, 2006 17:19 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantOption (right to buy) · Derivative | 75,000 | Not disclosed Strike: $19.33 | Not disclosed |
DisclosureSEC source: 0000310158-06-000021 · koe524.xml · derivative · entry 2 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Shares · 75,000 shares Expires 2013-03-19 F4 · price: Not Applicable. F5 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan, exercisable in one-third increments on March 21 of 2007, 2008 and 2009. Read SEC document |
| March 20, 2006 Filed Mar 22, 2006 17:19 UTC | Merck & Co., Inc. SGP · Entity 2807 | GrantDeferred Stock Unit Award · Derivative | 10,000 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0000310158-06-000021 · koe524.xml · derivative · entry 1 KOEHLER STEVEN H · CIK 0001144776 · Vice President and Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Shares · 10,000 shares Expires not disclosed F1 · derivative.exercise_price: Not Applicable. F4 · price: Not Applicable. F2 · derivative.exercise_date: Granted under the Schering-Plough Corporation 2002 Stock Incentive Plan. All of the shares become deliverable on March 20, 2009. F3 · derivative.expiration_date: Not Applicable. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.